CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Haller Julia A Director | Sale | −3,800 | $63.31 | $241K | 30,279 |
| 2026-09-09 | Massacesi Cristian EVP,Chief Med Offr,Head of Dev | Sale | −6,249 | $64.57 | $403K | 18,748 |
| 2026-08-25 | Holzer Phil M SVP and Controller | Sale | −500 | $67.50 | $34K | 16,862 |
| 2026-04-01 | Elkins David V EVP, Chief Financial Officer | Sale | −25,519 | $61.60 | $1.6M | 163,729 |
| 2026-04-01 | Elkins David V EVP, Chief Financial Officer | Sale | −4,481 | $62.05 | $278K | 159,248 |
| 2025-09-02 | Elkins David V EVP, Chief Financial Officer | Sale | −56,000 | $47.33 | $2.7M | 167,379 |
| 2025-08-02 | Short Bartie Wendy EVP, Corporate Affairs | Sale | −378 | $44.23 | $17K | 5,066 |
| 2025-05-09 | Hickey Benjamin President, RayzeBio Org. | Sale | −97.39 | $38.01 | $4K | 0 |
| 2024-11-04 | Holzer Phil M SVP and Controller | Sale | −700 | $55.62 | $39K | 11,760 |
Page 1 of 1 · 9 trades